Type 2 Diabetes
Q&A: Plant-based diet intervention helps patients achieve type 2 diabetes remission
An intervention based on a plant-predominant diet and education helped patients with type 2 diabetes achieve remission, a study published in the American Journal of Lifestyle Medicine showed.
How to tailor care for LGBTQ+ people living with diabetes
Susan Weiner, MS, RDN, CDN, CDCES, FADCES, talks with Tessa Cushman, RDN, about addressing health inequities for people living with diabetes who identify as LGBTQ+.
Top in endocrinology: FDA OKs empagliflozin for kids; hormonal effects of brain injury
The FDA has approved new oral therapies for children with type 2 diabetes — empagliflozin and a combination of empagliflozin and metformin hydrochloride — for the first time in more than 20 years.
Bariatric surgery linked to long-term HbA1c reduction, weight loss in type 2 diabetes
SAN DIEGO — Adults with obesity and type 2 diabetes who undergo bariatric or metabolic surgery have a lower HbA1c and greater weight loss than those who did not undergo surgery at 7 and 12 years of follow-up, according to trial data.
‘This raises the bar’: Phase 2 data show 24% weight loss with triple-agonist retatrutide
SAN DIEGO — Adults with obesity who received the highest dose of a once-weekly injection of retatrutide lost an average of 24.2% of their body weight at 48 weeks compared with placebo, data from a phase 2 study show.
Low-carb breakfast could help patients with type 2 diabetes manage glucose
Having a low-carbohydrate breakfast may be a simple method to reduce HbA1c for those with type 2 diabetes, according to the results of a randomized trial published in the American Journal of Clinical Nutrition.
Higher-dose oral semaglutide may be beneficial option for type 2 diabetes, obesity
SAN DIEGO — Oral semaglutide 50 mg induces more than 15% weight loss in adults with obesity at 68 weeks and can reduce HbA1c by 2 percentage points at 52 weeks for those with type 2 diabetes, according to data from two phase 3 trials.
VIDEO: ‘Vacation’ from diabetes is possible
SAN DIEGO — In this video exclusive, Sangeeta Kashyap, MD, discusses how weight loss is the key to type 2 diabetes remission and how remission can be possible in both short- and long-term scenarios.
ONWARDS 1: Benefits of once-weekly vs. daily insulin sustained through 83 weeks
SAN DIEGO — Adults with type 2 diabetes naive to insulin therapy saw a long-term reduction in HbA1c and superior time in the recommended glucose range with once-weekly insulin icodec compared with daily insulin glargine, data show.
SURMOUNT-2: Tirzepatide confers about 15% weight loss in adults with obesity and diabetes
SAN DIEGO — Adults with obesity and type 2 diabetes achieved a 14.7% weight loss at 72 weeks with 15 mg tirzepatide, according to data from the SURMOUNT-2 trial presented at the American Diabetes Association Scientific Sessions.